Aggarwal, Rohit | USA
Biard, Lucie |France
Boyer, Olivier | France
Crow, Yanick | France
Deakin, Claire | UK
Eleftheriou, Despina | UK
Gitiaux, Cyril | France
Hermine, Olivier | France
Kishi, Takayuki | Japan
Kjaer, Michael | Denmark
Klareskog, Lars | Sweden
Kuwana, Masataka | Japan
Moslehi, Javid J. | USA
Schultze, Joachim | Germany
Stenzel, Werner | Germany
Straub, Volker | UK
Takayuki, Kishi | Japan
Van Wijk, Femke | The Netherlands
Voit, Thomas | UK
Weihl, Conrad C. | USA
Dr. Rohit Aggarwal, MD, MS is an associate professor of medicine, rheumatologist and medical director of arthritis and autoimmunity center at University of Pittsburgh, Pittsburgh, USA. He is also the co-director of Pittsburgh Myositis Center. His key areas of interest include outcomes measures and clinical trials in idiopathic inflammatory myopathies as well as associated interstitial lung disease. He is also leading various classification and response criteria effort in myositis.
MD specialized in Public Health (Paris Descartes University, 2013), PhD in Biostatistics (Paris Diderot University, 2016), currently postdoctoral researcher in INSERM U1153 team ECSTRRA in Saint Louis hospital in Paris, France. Assistant professor from 2013 to 2017 at Paris Diderot University then postdoctoral researcher at Columbia University MailmanSchool of Public Health in 2018, my activities have involved teaching, research in biostatistics, and methodology and statistical consulting for clinical research projects on medical campuses, in particular in oncology, hematology, intensive care and internal medicine. My main research interests in biostatistics are survival data analysis, clustered data, Bayesian methods, early phase adaptive clinical trials and rare diseases.
Olivier Boyer, MD, PhD, is Professor of immunology at the Faculty of Medicine of Normandy Rouen University and head of Inserm U1234 research laboratory (autoimmunity, cell and gene therapy). His group has developed different immunoassays for detecting, quantifying and characterizing several myositis-specific autoantibodies. His research is mainly focused on myositides with the aim of better understanding their pathogenic mechanisms (pathogenicity of autoantibodies, animal models of myositis, adaptive immune responses…) and ameliorating their diagnosis and treatment.
Crow is an MD, PhD with a particular interest in Mendelian disorders associated with enhanced type I interferon signalling, now working between the University of Edinburgh and the Institut Imagine in Paris. Yanick has been involved in the definition of a number of diseases resulting from a disturbance of nucleic acid metabolism or sensing, and in the development of screening tools for the identification of such type I interferonopathies. More recently, this work has led to preliminary attempts at treatment – premised on the blocking of the induction or signalling of type I interferon. Yanick’s research stands at the crossroads of several fields, including clinical medicine (neurology, rheumatology, dermatology), human genetics and cytokine biology.
Dr Claire Deakin is a Senior Research Associate in the NIHR Biomedical Research Centre at Great Ormond Street Hospital and the Arthritis Research UK Centre for Adolescent Rheumatology at UCL, UCL Hospital and Great Ormond Street Hospital. Her research interests include obtaining insights into juvenile dermatomyositis (JDM) from genetic and transcriptomic analyses, and understanding long-term outcomes for patients with JDM using longitudinal modeling methods.
I am an Associate Professor in paediatric and adolescent rheumatology based in the Institute of Child Health, UCL London and Great Ormond Street Hospital. I have developed a successful academic programme of work dedicated to the developing field of paediatric vasculitis and autoinflammation (outcome measures, gene hunting, clinical trials and gene therapy ) in concert with a world leading clinical service at Great Ormond Street Hospital.
Dr Gitiaux is an expert in neuromuscular physiology and diseases (child neurologist and child neurophysiologist). He belongs to the pediatric neuromuscular diseases referral center of Paris and to the research team U955-E10, Team 10: Biology of the neuromuscular sytem, Group 2: Pathophysiological and innovatives therapies in neuromuscular diseases ». He participates in several translational clinical research projects in the following fields: -Biomarkers in acquired and hereditary neuropathies; -Cell interactions in muscle regeneration; -Arthrogryposis; -Pediatric inflammatory myositis.
Takayuki Kishi is an Assistant Professor at the Department of Pediatrics at the Tokyo Women’s Medical University Hospital with board certification as pediatric Neurologist and Padiatrician. Before that, he was a Research Fellow in the group for Environmental Autoimmunity at the National Institute of Environmental Health Sciences in Bethesda, USA.
Michael Kjaer has a medical degree from Univ of Copenhagen Denmark, and has specialized in rheumatology. He is a professor of Sports Medicine at the University of Copenhagen and heads the Institute of Sports Medicine at Bispebjerg Hospital. His research focuses on adaptive responses of skeletal muscle and connective tissue to physical exercise and ageing.
Lars Klareskog is senior professor of rheumatology at Karolinska Institutet (KI) and has been the chairman of the academic department of rheumatology at KI between 1993 and 2012, and also been member of the Nobel Assembly and Nobel Committee at KI 1995-2012 and chairman of the Assembly 2011. His main research interests are in translational medicine, i.e. in understanding etiology and molecular pathogenesis of inflammatory rheumatic diseases and to use such knowledge for the development of therapy and prevention of these diseases.
Dr. Masataka Kuwana is a Professor of Allergy and Rheumatology at Nippon Medical School in Tokyo, Japan. After completion of the fellowship program at the Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Dr. Kuwana spent his professional career focusing on basic and clinical aspects of a variety of systemic and organ-specific autoimmune diseases. He has published more than 350 peer-reviewed scientific articles and written more than 10 book chapters. His main research interests include systemic sclerosis, idiopathic inflammatory myopathies, pulmonary complications of connective tissue diseases, and autoimmunity.
Moslehi, Javid J.
Dr. Javid Moslehi is a clinical cardiologist and a physician-scientist. He is an Assistant Professor of Medicine at Vanderbilt University Medical Center where he also directs the cardio-oncology program. Dr. Moslehi’s basic and translational group is interested in mechanistic delineation of cardiovascular toxicities of cancer therapies. He has more recently been interested in immune checkpoint-inhibitor associated myotoxicities.
Werner Stenzel is Professor at the Department of Neuropathology at The Charité – University Hospital in Berlin, Germany. He is a board certified Neurologist and Neuropathologist. His clinical diagnostic focus is inflammatory diseases of the neuromuscular system and his research focusses on inflammatory myopathies.
Volker Straub is Professor of Neuromuscular Genetics at Newcastle University in the UK. He is the Deputy Director of the Institute of Genetic Medicine and the Director of the Newcastle University John Walton Muscular Dystrophy Research Centre. The Centre focusses on translational research with the overall goal to accelerate the development and delivery of treatments for patients with neuromuscular diseases.
Van Wijk, Femke
Femke van Wijk works as an Associate Professor in translational immunology at the University Medical Centre Utrecht. Her research is focused on human immune regulation in chronic inflammatory disease, addressing conceptual and mechanistic immunological questions with a strong link to the clinic, both in paediatric and adult patients. By unravelling key immunological pathways that are involved in the chronic inflammatory processes she aims to capture immune fingerprints and bio-profiles of disease and disease subtypes. Her strong collaboration with clinicians stimulates translation of findings into clinical or diagnostic applications, e.g. tools to monitor disease or predict disease or treatment outcomes. Together with Dr. Annet van Royen MD, her group has identified and validated a novel biomarker for juvenile dermatomyositis (JDM). In an international JDM research program they hope to develop an individual treatment scheme for every child with JDM, based on different parameters including disease activity at onset, skin scores, autoantibodies and biomarkers.
Weihl, Conrad C.
Dr. Conrad “Chris” Weihl, a Professor of Neurology at Washington University School of Medicine in St. Louis, studies how a cell’s failure to maintain quality control over its proteins – and, especially, to dispose of or reshape deformed and clumped proteins – can lead to degenerative diseases. Dr. Weihl received his MD and PhD from the University of Chicago Pritzker School of Medicine and received his clinical neurology and neuromuscular training at Washington University in St. Louis with Dr. Alan Pestronk. He has an active research program focusing on hereditary and acquired forms of muscle degeneration. His research utilizes cell and animal models to define novel pathogenic mechanisms of disease. Similarly, his clinical interests relate to both acquired and inherited muscle diseases including limb girdle muscular dystrophy and inclusion body myositis.